Inspire Medical Systems ($INSP) reported its third-quarter 2024 earnings, revealing a revenue of $203.19 million, surpassing expectations of $197.60 million. The company also reported earnings per share (EPS) of $0.60, significantly higher than the anticipated $0.08. Masimo ($MASI) announced its Q3 2024 results with revenue of $504.60 million, slightly above the forecast of $502.67 million, and an EPS of $0.98 compared to the expected $0.84. Additionally, Globus Medical ($GMED) disclosed its third-quarter earnings, achieving revenue of $625.71 million, exceeding the expected $603.93 million, and an EPS of $0.83, up from the anticipated $0.65. All three companies released their financial results after the market closed on November 5, 2024.